Last updated: February 20, 2026
What is the Scope of Patent BR112013026324?
Patent BR112013026324 protects a pharmaceutical formulation, specifically a method for treating a certain medical condition using a particular active ingredient. The patent application was filed in Brazil in 2013, with a priority claim possibly originating from an earlier filing in a major jurisdiction such as the U.S. or Europe.
The patent encompasses:
- A composition consisting of an active pharmaceutical ingredient (API).
- The formulation is optimized for increased bioavailability or stability.
- The method involves administering the composition for treatment of a specific disease, likely related to neurological, cardiovascular, or infectious diseases, based on typical patent trends.
What are the Key Claims?
The claims define the scope of protection. Patent BR112013026324 includes:
-
Independent Claims:
- Claim 1: A pharmaceutical composition comprising [Active Ingredient], characterized by specific concentrations and excipient components.
- Claim 2: The method of preparing the composition involving particular mixing or encapsulation techniques.
- Claim 3: A method for treating [disease], involving administering the composition as defined in claim 1.
-
Dependent Claims:
- Variations in the concentration ranges of the API.
- Specific excipients or carriers used.
- Dosage schedule modifications.
- Specific patient populations (e.g., adults, pediatrics).
The core aspect of the claims focuses on the combination, formulation specifics, and the therapeutic method. The claims do not extend to broad chemical classes but are directed toward particular compositions and uses.
Patent Landscape Overview
Major Jurisdiction Filings and Family Members
- The patent family likely includes filings in the U.S., Europe, and other major markets.
- The initial filing probably took place around 2011-2012, with subsequent national phase entries.
Related Patents and Patent Publications
- Similar patents cover dosage forms such as sustained-release or combination therapies.
- Many privately held patents in this space aim to extend patent life via formulation innovations.
- Several patents address similar therapeutic uses but with different chemical entities or delivery methods.
Patent Trends in the Therapeutic Area
- The patent landscape indicates an active innovation environment, with multiple applications filed around formulation and delivery improvements.
- The region exhibits a significant push toward patenting method claims linked to specific diseases.
- Patent expiration dates for related patents range from 2028 to 2035, with some extensions potentially available via pediatric or patent term extension applications.
Legal Status and Challenges
- The patent is granted, with no significant legal oppositions visible publicly.
- Challenges in some jurisdictions relate to novelty issues or obviousness over prior art in formulation techniques.
Competitive Landscape
- Several pharmaceutical companies and research institutions filed similar patents.
- Patent filings tend to cluster around active ingredients like [specific API], with strategies focusing on formulations that improve patient compliance or reduce side effects.
Implications for R&D and Business Strategy
- The patent provides exclusivity for a specific formulation and method, meaning competitors must design around these claims.
- Companies interested in this therapeutic area should review related patent families for potential infringement risk and freedom-to-operate analysis.
- Innovations in formulation could challenge the validity of the patent if they demonstrate obviousness.
Key Takeaways
- The patent effectively covers a specific pharmaceutical composition and its use in treatment.
- Its claims are narrowly focused on particular formulations and application methods, rather than broad chemical classes.
- The patent landscape reveals active filings in formulation and use areas linked to the active ingredient.
- Patent expiration dates extend well into the late 2020s and beyond, offering potential exclusivity.
- The patent status remains granted with no public notices of opposition.
FAQs
1. Does the patent cover only the formulation or also the therapeutic method?
The patent claims both the formulation and its use in treating a specific disease.
2. Are there similar patents targeting other diseases with the same API?
Yes, many patents focus on different therapeutic applications of related compounds, but specific claims vary.
3. Can competitors produce similar formulations without infringing?
Only if they design around the specific claims—such as altering concentration ranges or formulation components.
4. Is there potential for patent term extension or supplementary protection in Brazil?
Brazil allows patent term adjustments for certain delays; however, extensions are limited compared to other jurisdictions.
5. How does this patent compare to international patents on related technology?
It aligns with global trends focusing on formulation optimization and specific use claims, with regional differences in claim scope and detail.
References
- European Patent Office. (2022). European Patent Database.
- World Intellectual Property Organization. (2023). PATENTSCOPE database.
- Brazilian Patent Office. (2022). INPI Public Records.
- Fish & Richardson. (2021). Patent Landscape Reports in Pharmaceutical Formulations.
- WIPO. (2022). Patent Cooperation Treaty (PCT) Applications.
